The diet-induced non-alcoholic fatty liver disease (NAFLD) model is established by feeding animals with high-fat and high-sugar diets, leading to overnutrition – the excessive amounts of lipids, cholesterol, and/or carbohydrates in the food cannot be fully absorbed and utilized. This overnutrition results in lipids accumulation, further inflammatory changes, and fibrosis. This model is the most commonly used NAFLD animal model for human NAFLD research. Different diet-induced models vary in characteristics, as shown below:
|Model||Mouse Type||Obesity||Insulin Resistance (IR)||Dyslipidemia||Elevated Transaminase||Fatty Degeneration of Liver||Hepatic Fibrosis|
|High-fat Diet Model||Mouse||Y||Y||Y||Y||Y||-|
|High-sugar Diet Model||Mouse||-||Y||Y||N||Y||-|
|High-fat & High-sugar Diet Model||Mouse||Y||Y||Y||Y||Y||Y|
|Methionine & Choline Deficient Diet Model||Mouse||N||N||N||Y||Y||Y|
Note: Y: Yes, N: No, (-): without report
Detection Items: Body weight, food intake, serum biochemical test (alanine aminotransferase, aspartate aminotransferase, serum total cholesterol, triglyceride content, etc.), pathological analysis of liver tissue (liver tissue H & E staining, oil red).
Cyagen can provide you with a variety of drug evaluation models along with phenotype analysis services – delivering reliable and expedient data reporting for your project.
Please see below for supporting information related to Cyagen animal orders.